170 related articles for article (PubMed ID: 5065660)
1. Structure-activity relationships: nitrosoureas.
Johnston TP
Cancer Chemother Rep 3; 1972 May; 3(1):50-1. PubMed ID: 5065660
[No Abstract] [Full Text] [Related]
2. Chemistry and structure-activity studies of the nitrosoureas.
Montgomery JA
Cancer Treat Rep; 1976 Jun; 60(6):651-64. PubMed ID: 954007
[TBL] [Abstract][Full Text] [Related]
3. Comparison of mutagenicity, antitumor activity, and chemical properties of selected nitrosoureas and nitrosoamides.
Brundrett RB; Colvin M; White EH; McKee J; Hartman PE; Brown DL
Cancer Res; 1979 Apr; 39(4):1328-33. PubMed ID: 421216
[TBL] [Abstract][Full Text] [Related]
4. The synthesis of potential anticancer agents. XXXVI. N-nitrosoureas. II. Haloalkyl derivatives.
Johnston TP; McCaleb GS; Opliger PS; Montgomery JA
J Med Chem; 1966 Nov; 9(6):892-911. PubMed ID: 5972051
[No Abstract] [Full Text] [Related]
5. Contributions of nitrosoureas to cancer treatment.
Mitchell EP; Schein PS
Cancer Treat Rep; 1986 Jan; 70(1):31-41. PubMed ID: 3002621
[No Abstract] [Full Text] [Related]
6. Relationship of structure to anticancer activity and toxicity of the nitrosoureas in animal systems.
Johnston TP; Montgomery JA
Cancer Treat Rep; 1986 Jan; 70(1):13-30. PubMed ID: 2935250
[No Abstract] [Full Text] [Related]
7. [Antitumor effect of compounds synthesized in the Division of Synthetic Chemistry (V) (author's transl)].
Miyahara M; Kamiya S; Nakadate M; Sueyoshi S; Tanno M; Miyahara M
Eisei Shikenjo Hokoku; 1981; 99():111-3. PubMed ID: 7332796
[No Abstract] [Full Text] [Related]
8. Separate and sequential chemotherapy of mouse leukemia L1210 with 1-beta-D-arabinofuranosylcytosine hydrochloride and 1,3-bis(2-chloroethyl)-1-nitrosourea.
Tyrer DD; Kline I; Venditti JM; Goldin A
Cancer Res; 1967 May; 27(5):873-9. PubMed ID: 6025252
[No Abstract] [Full Text] [Related]
9. Success and failure in the treatment of solid tumors. 3. "Cure" of metastatic Lewis lung carcinoma with methyl-CCNU (NSC-95442) and surgery-chemotherapy.
Mayo JG; Laster WR; Andrews CM; Schabel FM
Cancer Chemother Rep; 1972 Apr; 56(2):183-95. PubMed ID: 5043226
[No Abstract] [Full Text] [Related]
10. Studies on the chemotherapy of experimental brain tumors: evaluation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, vincristine, and 5-fluorouracil.
Shapiro WR
J Natl Cancer Inst; 1971 Feb; 46(2):359-68. PubMed ID: 4256014
[No Abstract] [Full Text] [Related]
11. Effects of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) and its degradation products on progression of L1210 cells through the cell cycle.
Bray DA; DeVita VT; Adamson RH; Oliverio VT
Cancer Chemother Rep; 1971 Jun; 55(3):215-20. PubMed ID: 5115843
[No Abstract] [Full Text] [Related]
12. Biological activity of hydroxylated chloroethylnitrosoureas.
Zeller WJ; Frühauf S; Chen G; Eisenbrand G; Lijinsky W
Cancer Res; 1989 Jun; 49(12):3267-70. PubMed ID: 2720679
[TBL] [Abstract][Full Text] [Related]
13. Effect of treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or cyclophosphamide on spleen colony-forming units and survival time of leukemic mice.
Vadlamudi S; Waravdekar VS; Choudry JN; Goldin A
Cancer Res; 1968 Jul; 28(7):1242-9. PubMed ID: 5665982
[No Abstract] [Full Text] [Related]
14. Antitumor structure-activity relations. Nitrosoureas vs. L-1210 leukemia.
Hansch C; Leo A; Schmidt C; Jow PY; Montgomery JA
J Med Chem; 1980 Oct; 23(10):1095-101. PubMed ID: 7420354
[TBL] [Abstract][Full Text] [Related]
15. 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962) and methotrexate (NSC-740) as combination therapy for advanced mouse leukemia L1210.
Venditti JM; Kline I; Tyrer DD; Goldin A
Cancer Chemother Rep; 1965 Oct; 48():35-9. PubMed ID: 5834736
[No Abstract] [Full Text] [Related]
16. Nitrosoureas: 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962; BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC-79037; CCNU)--clinical brochure.
Carter SK; Newman JW
Cancer Chemother Rep 3; 1968 Dec; 1(1):115-51. PubMed ID: 4917773
[No Abstract] [Full Text] [Related]
17. Evaluation of antileukemic agents in advanced leukemia L1210 in mice. X.
Kline I; Gang M; Tyrer DD; Venditti JM; Artis EW; Goldin A
Cancer Chemother Rep 2; 1972 Nov; 3(1):1-69. PubMed ID: 4660732
[No Abstract] [Full Text] [Related]
18. Topical lomustine in the treatment of psoriasis.
Peck GL; Guss SB; Key DJ
Arch Dermatol; 1972 Aug; 106(2):172-6. PubMed ID: 4558698
[No Abstract] [Full Text] [Related]
19. Treatment of advanced Hodgkin's disease with (1,3 bis (2-chloroethyl)-1-nitrosourea) BCNU.
Young RC; DeVita VT; Serpick AA; Canellos GP
N Engl J Med; 1971 Aug; 285(9):475-9. PubMed ID: 5558887
[No Abstract] [Full Text] [Related]
20. Historical development and future promise of the nitrosoureas as anticancer agents.
Schabel FM
Cancer Chemother Rep 3; 1973 May; 4(3):3-6. PubMed ID: 4584035
[No Abstract] [Full Text] [Related]
[Next] [New Search]
